Endurant Capital Management’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q3
Sell
-4,700
Closed -$281K 105
2017
Q2
$281K Buy
4,700
+700
+18% +$41.9K 0.08% 89
2017
Q1
$213K Sell
4,000
-10,800
-73% -$575K 0.07% 87
2016
Q4
$739K Buy
14,800
+9,000
+155% +$449K 0.31% 59
2016
Q3
$348K Buy
+5,800
New +$348K 0.13% 82
2016
Q2
Sell
-17,500
Closed -$516K 98
2016
Q1
$516K Buy
+17,500
New +$516K 0.17% 70